Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracordal trafermin for vocal fold atrophy and sulcus vocalis
jRCTs031220682Active, not recruiting
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of trafermin in vocal fold atrophy, presbylaryngis and Sulcus Vocalis (SV). Started Jun 2023; status: active, not recruiting.
02
Drugs
trafermin
03
Conditions
vocal fold atrophypresbylaryngisSulcus Vocalis (SV)
Beyond the preview
Go deeper on jRCTs031220682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220682.